Clarity Medical Group Holding Ltd (1406) Fair Value & Analysis
Healthcare · HK · Market cap HK$190M
Fair value as of: Aug 13, 2026
From 1 valuation models · updated 3 days ago
Below-average quality, and screening another 35% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (HK$0.2900). The favourable scenario is already priced in.
- Weak quality (32/100) and above fair value at the same time, the margin of safety is missing on both counts.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
- A fairly wide model range (HK$0.1500 to HK$0.2900) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
54‑month range HK$0.3350 – HK$1.54 · fair‑value band HK$0.1500 – HK$0.2900 · the HK$0.3550 price screens above the HK$0.2300 fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Clarity Medical Group Holding Ltd (1406) currently trades at HK$0.3550, while our model-based Fair Value estimate is HK$0.2300, implying the stock looks roughly 35.2% overvalued today. The Quality Score stands at 32/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Over the trailing twelve months, Clarity Medical Group Holding Ltd generated revenue of HK$177M at a net margin of -42.1%. Revenue declined 14.2% year over year. It earns a return on equity of -35.8%. Fundamentals as of Aug 13, 2026
Our scenario range runs from HK$0.1500 (bear case) to HK$0.2900 (bull case); at HK$0.3550, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -46% fair-value upside, at -35%, 1406 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 1 models by family
Notify me when 1406 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 39 · Market factors (momentum, volatility) 56
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Clarity Medical Group Holding Limited, an investment holding company, provides ophthalmic healthcare services in Hong Kong. The company offers refractive treatment services, including SMILE and LASIK surgeries, multifocal implantable intraocular lens replacements, and implantable collamer lens implantations.
Full company description
Clarity Medical Group Holding Limited, an investment holding company, provides ophthalmic healthcare services in Hong Kong. The company offers refractive treatment services, including SMILE and LASIK surgeries, multifocal implantable intraocular lens replacements, and implantable collamer lens implantations. It also provides treatments for other eye problems, such as standard cataract surgeries, pars plan vitrectomy surgeries, laser procedures, and other treatments and surgeries. In addition, the company offers consultation and examination services, including visual acuity, refraction, anterior segment examination, fundal examination, and intraocular pressure measurement; consultancy services; and sells prescriptions and others. Clarity Medical Group Holding Limited was founded in 2005 and is headquartered in Kowloon, Hong Kong.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2020 – FY2024 · reported fiscal years
Clarity Medical Group Holding Ltd reported revenue of HK$191M in FY2024 versus HK$218M in FY2020, a compound −3.3%/yr. Reported net income was −HK$75.8M in FY2024.
1406 screens 35% overvalued. Compare with Intuitive Surgical, Inc →
Peer Group
Medical Instruments & Supplies · 202 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Instruments & Supplies median · lower = cheaper
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $401.27 | $150.04 | -63% |
| EssilorLuxottica Société anonyme 1EL | €164.40 | €68.55 | -58% |
| Medline Inc MDLN | $35.50 | $30.15 | -15% |
| Becton, Dickinson and Company BDX | $181.41 | $100.46 | -45% |
| Alcon Inc ALC | $73.58 | $39.78 | -46% |
| ResMed Inc RMD | $226.00 | $187.89 | -17% |
| West Pharmaceutical Services, Inc WST | $352.29 | $141.58 | -60% |
| Sartorius Stedim Biotech S.A DIM | €180.30 | €48.88 | -73% |
| Coloplast A/S COLOB | kr 429.70 | kr 382.22 | -11% |
| Gan & Lee Pharmaceuticals., a biopharmaceutical company, 603087 | ¥77.48 | ¥27.22 | -65% |
Compare Clarity Medical Group Holding Ltd with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Clarity Medical Group Holding Ltd (1406) overvalued or undervalued?
What is the fair value of 1406?
What is the quality score of 1406?
What is the revenue of Clarity Medical Group Holding Ltd (1406)?
What is the net profit margin of 1406?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Clarity Medical Group Holding Ltd and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.